Lonc-term safety of TNF-blockers

被引:0
|
作者
Van Vollenhoven, R. [1 ]
机构
[1] Karolinska Inst, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
下载
收藏
页码:720 / 720
页数:1
相关论文
共 50 条
  • [11] No increase of severe infections in RA patients treated with TNF-blockers
    Jacobsson, LTH
    Turesson, C
    Gülfe, A
    Kapetanovic, MC
    Petersson, IF
    Saxne, T
    Geborek, P
    ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : S341 - S341
  • [12] No increase of severe infections in RA patients treated with TNF-blockers
    Jacobsson, LTH
    Turesson, C
    Gülfe, A
    Kapetanovic, MC
    Petersson, IF
    Saxne, T
    Geborek, P
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 461 - +
  • [13] Novel approaches to develop biomarkers predicting treatment responses to TNF-blockers
    Mezghiche, Ikram
    Yahia-Cherbal, Hanane
    Rogge, Lars
    Bianchi, Elisabetta
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (04) : 331 - 354
  • [14] Tocilizumab. What comes after TNF-blockers in clinical routine?
    Roll, P.
    Rubbert-Roth, A.
    Tony, H. -P.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2010, 69 (07): : 608 - +
  • [15] Methotrexate and TNF-Blockers for Post Chikungunya Chronic Arthritis : The Martinican Experience
    Blettery, Marie
    Brunier-Agot, Lauren
    Mary, Julia
    Polomat, Katlyne
    Moinet, Florence
    Deligny, Christophe
    Arfi, Serge
    Jean Baptiste, Georges
    De Bandt, Michel
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [16] CARDIOVASCULAR RISK IN SPONDYLOARTHROPATHIES (SPA) AND RHEUMATOID ARTHRITIS (RA) ON LONGSTANDING TNF-BLOCKERS
    Khan, T. A.
    Cuchacovich, R.
    Hagan, J.
    Patel, N.
    Espinoza, L. R.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2010, 58 (02) : 373 - 373
  • [17] Efficacy of ustekinumab in sub-erythrodermic psoriasis: when TNF-blockers fail
    Buggiani, Gionata
    D'Erme, Angelo Massimiliano
    Krysenka, Alena
    Pescitelli, Leonardo
    Lotti, Torello
    Prignano, Francesca
    DERMATOLOGIC THERAPY, 2012, 25 (03) : 283 - 285
  • [18] Treatment with TNF-blockers is associated with reduced premature mortality in patients with rheumatoid arthritis
    Jacobsson, L. T. H.
    Turesson, C.
    Nilsson, J.
    Petersson, I. F.
    Lindqvist, E.
    Saxne, T.
    Geborek, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 506 - 506
  • [19] THE RELATIONSHIP OF BIOMARKERS AND RADIOGRAPHIC PROGRESSION IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH TNF-BLOCKERS
    Baraliakos, X.
    Landewe, R.
    van der Heijde, D.
    Listing, J.
    Baker, D.
    Hsu, B.
    Braun, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 625 - 625
  • [20] Response to pneumococcal vaccination in patients with rheumatoid arthritis treated with TNF-blockers and/or methotrexate.
    Crnkic, M
    Saxne, T
    Sjöholm, A
    Truedsson, L
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S658 - S659